HISUN(SH:600267) Ge Long Hui A P P·2026-01-16 08:27Core Viewpoint - Zhejiang Securities Regulatory Bureau issued a warning letter to Zhejiang Haizheng Pharmaceutical Co., Ltd. and related personnel due to the company's disclosure of inaccurate financial information in its annual reports for the years 2021-2024 [1] Financial Corrections - The company announced corrections to its financial data, including operating revenue, operating costs, and investment income, in a notice dated August 26, 2025 [1] - The corrections indicate that the previously disclosed financial information was not true or accurate [1] Regulatory Actions - The Zhejiang Securities Regulatory Bureau decided to issue warning letters as a supervisory measure to the company and several individuals, including Jiang Guoping, Shen Xinghu, Li Yan, Xiao Weihong, Zhang Zhenying, and Shen Xifei [1] - These actions will be recorded in the integrity archives of the securities and futures market [1]